Signaling pathways
-
BA9029 ER-27319Summary: ER-27319 is an acridone derivative. -
BA9030 UNC2541Summary: UNC2541 is a potent Mer tyrosine kinase-specific inhibitor.
-
BA9031 UNC569Summary: UNC569 is a potent, reversible, ATP-competitive and orally active kinase inhibitor.
-
BA9032 RU-301Summary: RU-301 is a pan-type inhibitor that blocks induced activation and tumorigenicity.
-
BA9033 UNC1062Summary: UNC1062 is a selective tyrosine kinase inhibitor that reduces MERTK-mediated activation of downstream signaling, induces apoptosis in culture, reduces colony formation in soft agar, and inhibits melanoma cell invasion.
-
BA9034 TAM-IN-2Summary: TAM inhibitors.
-
BA9035 BatiraxceptSummary: Batiraxcept (AVB-S6-500) is a highly potent and specific, recombinant fusion protein dimer containing the human extracellular region and human immunoglobulin G1 heavy chain (Fc).
-
BA9036 RU-302Summary: RU-302 is a non-selective inhibitor that blocks the interface between the TAMIg1 extracellular domain and the Gas6Lg structural domain.
-
BA9037 TL4830031Summary: TL4830031 is a quinolone antibiotic derivative.
-
BA9038 VEGFR-2-IN-39Summary: VEGFR-2-IN-39 (PROTAC-5) was targeted (208.6 nM).